MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Pro

Altimmune's $225 Million Capital Raise: A Necessary Lifeline

4 hours ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

LOBO's Latest Capital Raise: A Lifeline or a Dilution Trap

1 months ago

What's Driving Itron's Latest Capital Raise

1 months ago

What Does Erayak Power's Recent Capital Raise Really Mean for Investors

1 week ago

Is Whirlpool's $963 Million Capital Raise a Strategic Masterstroke or a Sign of Strain

1 months ago

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

Altimmune priced a $225 million public offering of common stock and warrants at $3.00 per unit. The offering, which includes 75 million shares and accompanying warrants, is expected to close on April ...

ALT

Stock News•3 days ago

Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round

Pulnovo Medical raised $100M in an oversubscribed financing round led by a strategic investment from Medtronic. The capital will support the company’s development of breakthrough therapies for pulmona...

Stock News•1 week ago

Forte Biosciences: Stunning Bull Run Could Continue Thanks To Near-Term Data Readouts

Forte Biosciences raised $150M in capital this week to advance its FB102 antibody program. The company reported statistically significant Phase 1b efficacy in Celiac disease, positioning the drug as a...

FBRX

Stock News•2 weeks ago

Vertical Aerospace Lands $850M Lifeline: What It Means for Investors

Vertical Aerospace (EVTL) secured $850M in new financing, significantly extending its liquidity runway. This capital injection addresses the company's urgent need for funds to support its capital-inte...

EVTL